Occam Expands European Practice with CFO Placement
In early 2025, Occam Global placed McDavid Stilwell as CFO of CPTx, a company pioneering the development of in vivo genetic medicines built on single-stranded DNA. CPTx’s lead development programs include a next-generation in vivo CAR-T therapy and a novel, programmable, non-viral self-delivering gene nanocarrier.
Stilwell is an industry veteran with more than 25 years of experience in finance, corporate development, investor relations, and communications. Previously, he served as CFO at Coherus Biosciences as the company launched multiple new products into the US market. Earlier in his career, he held leadership roles at Sangamo Therapeutics, a pioneer in gene editing, and several other biotech companies.
Stilwell received a BA from St. John’s College and an MBA from Harvard Business School.
Recent Placements
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies. Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.